Treatment of anaemia in chronic renal failure
Beer, J.
Nursing Times 84(47): 55-57
1988
ISSN/ISBN: 0954-7762 PMID: 3211795 Document Number: 317076
Document emailed within 1 workday
Related Documents
Swanepoel, C.R.; Moosa, M.R.; Rowland, G.F.; Meyers, A.M.; Botha, B.P.; Smart, A.J.; Goodman, R.; Schall, R.; Keogh, H.J.; Merrifield, E.H. 1996: Clinical experience with Repotin, a locally produced recombinant human erythropoietin, in the treatment of anaemia of chronic renal failure in South Africa South African Medical Journal 86(10): 1266-1269Dimitrakov, D.; Kumchev, E.; Tllkian, E. 1994: Study of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with chronic renal failure Folia Medica 36(3): 31-36
von Hartitzsch, B.; Kerr, D.N.; Morley, G.; Marks, B. 1977: Androgens in the anaemia of chronic renal failure Nephron 18(1): 13-20
Edmondson, R.P.; Ong, Y.W.; Chang, C.H.; Lim, C.H. 1982: Studies on the anaemia of Asian patients with chronic renal failure undergoing regular haemodialysis Annals of the Academy of Medicine Singapore 11(1): 15-23
Little, P.J.; Buttimore, A.; Gillies, A.L. 1975: The treatment of chronic renal failure in New Zealand New Zealand Medical Journal 81(531): 1-3
Goupil, A.; Baglin, A.; Clavel, B.; Verger, C.; Fritel, D. 1980: Chronic renal failure after CCNU treatment La Nouvelle Presse Medicale 9(41): 3069-3070
Seferyńska, I. 1991: Pathogenesis and treatment of anemia in chronic renal failure Polski Tygodnik Lekarski 46(4-5): 87-90
Weber, H. 1975: Peritoneal dialysis. Treatment of chronic renal failure Journal of the Kansas Medical Society 76(2): 23-28
Bohle, A.; Müller, G.A.; Wehrmann, M.; Mackensen-Haen, S.; Xiao, J.C. 1996: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides Kidney International. Suppl 54: S2-S9
Verkhovskiĭ, B.D.; Shcherbakova, E.O.; Cherniakov, V.L.; Ivanova, Z.I.; Zimin, B.P. 1977: Hemodialysis in the treatment of acute and chronic renal failure in children Pediatriia 2: 52-56
Gin, H.; Perlemoine, C.; Raffaitin, C.; Rigalleau, V. 2006: Treatment of type Ii diabetic patients with chronic renal failure Nephrologie and Therapeutique 2(Suppl 1): S59-S62
Marczewski, K.; Wójcik, J.; Janicka, L.; Bednarek-Skublewska, A.; Prasał, M.; Markiewicz, M. 1990: Arrhythmia in patients on dialysis treatment for chronic renal failure Wiadomosci Lekarskie 43(8): 313-317
McBride, A.J. 1975: A forcast of requirements for the treatment of chronic renal failure in Victoria Australian and New Zealand Journal of Medicine 5(5): 401-407
Dainiak, N. 1985: The role of androgens in the treatment of anemia of chronic renal failure Seminars in Nephrology 5(2): 147-154
Tanchev, I.; Genov, K.; Kurlova, E.; Stavreva, E.; Tancheva, D. 1982: Treatment of chronic renal failure by means of routine hemodialysis Vutreshni Bolesti 21(3): 53-61
Morley, A.; Holmes, K.; Forbes, I. 1974: Depletion of B lymphocytes in chronic hypoplastic marrow failure (aplastic anaemia) Australian and New Zealand Journal of Medicine 4(6): 538-541
Sesso, R.; Yoshihiro, M.M.; Ajzen, H. 1996: Late diagnosis of chronic renal failure and the quality of life during dialysis treatment Brazilian Journal of Medical and Biological Research 29(10): 1283-1289
Walser, M. 1978: Keto-analogues of essential amino acids in the treatment of chronic renal failure Kidney International. Supplement 1978(8): S180-S184
Klinger, M.; Szewczyk, Z.; Kazimierczak, K.; Kramarz, S. 1990: Cefoperazone--Possibility of safer treatment for infections in patients with chronic renal failure Wiadomosci Lekarskie 43(15-16): 773-776
González, F. 2003: Implementation of AUGE plan for chronic renal failure patients. The implementation of Universal Access and Explicit Guaranties Plan (AUGE), generates longer waiting lists among patients with chronic renal failure Revista Medica de Chile 131(5): 545-551